182 related articles for article (PubMed ID: 35747596)
1. Pembrolizumab-induced aseptic meningitis in a patient with non-small cell lung cancer: A case report and literature review of aseptic meningitis as an immune-related adverse event.
Inui G; Funaki Y; Makino H; Touge H; Arai K; Kuroda K; Hirayama Y; Kato R; Nonaka T; Yamane K; Teruya Y; Sueda Y; Sakamoto T; Yamaguchi K; Kodani M; Kawase S; Umekita Y; Horie Y; Nosaka K; Yamasaki A
Mol Clin Oncol; 2022 Jul; 17(1):120. PubMed ID: 35747596
[TBL] [Abstract][Full Text] [Related]
2. Immune-related aseptic meningitis diagnosed by Cube FLAIR on enhanced magnetic resonance imaging for a lung cancer patient administered atezolizumab: A case report.
Kuroda R; Nakagawa H; Uchida Y; Narumiya K; Tsunoda Y; Yamaguchi M; Oki T; Hiratsuka S; Nagatani Y; Nakano Y
Respirol Case Rep; 2023 Feb; 11(2):e01076. PubMed ID: 36605536
[TBL] [Abstract][Full Text] [Related]
3. Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC.
Toyozawa R; Haratake N; Toyokawa G; Matsubara T; Takamori S; Miura N; Yamaguchi M; Takenoyama M; Seto T
JTO Clin Res Rep; 2020 Mar; 1(1):100012. PubMed ID: 34589914
[TBL] [Abstract][Full Text] [Related]
4. Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab.
Lima G; Kahn A; Sama S; Savage J
Case Rep Oncol Med; 2019; 2019():7183747. PubMed ID: 31781445
[TBL] [Abstract][Full Text] [Related]
5. A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma.
Kawanaka H; Tajiri K; Muraishi N; Murayama A; Nukui T; Yasuda I
Case Rep Gastroenterol; 2024; 18(1):8-13. PubMed ID: 38188593
[TBL] [Abstract][Full Text] [Related]
6. Relapse of aseptic meningitis induced by ipilimumab and nivolumab therapy for metastatic renal cell carcinoma: A case report.
Takamatsu D; Furubayashi N; Negishi T; Ieiri K; Inoue T; Tsukino K; Nakamura M
Mol Clin Oncol; 2019 Dec; 11(6):590-594. PubMed ID: 31700625
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.
Thouvenin L; Olivier T; Banna G; Addeo A; Friedlaender A
Ther Adv Drug Saf; 2021; 12():20420986211004745. PubMed ID: 33854755
[TBL] [Abstract][Full Text] [Related]
8. Zanubrutinib-induced aseptic meningitis: a case report and literature review.
Yang J; Wang L; Zhong X; Yang C; Wu Y
Front Pharmacol; 2023; 14():1242491. PubMed ID: 37727390
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case.
Minami S; Okada H; Ihara S; Tsuji H; Yamadera M; Yasuoka H
J Med Cases; 2021 Sep; 12(9):359-365. PubMed ID: 34527106
[TBL] [Abstract][Full Text] [Related]
10. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.
Sekul EA; Cupler EJ; Dalakas MC
Ann Intern Med; 1994 Aug; 121(4):259-62. PubMed ID: 8037406
[TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab-induced severe oral mucositis in a patient with squamous cell carcinoma of the lung: A case study.
Yoon SY; Han JJ; Baek SK; Kim HJ; Maeng CH
Lung Cancer; 2020 Sep; 147():21-25. PubMed ID: 32652370
[TBL] [Abstract][Full Text] [Related]
12. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
[TBL] [Abstract][Full Text] [Related]
13. Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.
Baroz AR; Mambetsariev I; Fricke J; Pharaon R; Tan T; Kidambi T; Sandhu KS; Koczywas M; Salgia R
Cureus; 2021 Jul; 13(7):e16266. PubMed ID: 34377604
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.
Niki M; Nakaya A; Kurata T; Nakahama K; Yoshioka H; Kaneda T; Kibata K; Ogata M; Nomura S
Mol Clin Oncol; 2019 Feb; 10(2):267-269. PubMed ID: 30680206
[TBL] [Abstract][Full Text] [Related]
15. A Case of Ketorolac-Induced Aseptic Meningitis.
Shahin L; Rogers A; Swain L; Ourn FF; Barber T
Cureus; 2024 Mar; 16(3):e57349. PubMed ID: 38690497
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab induced aseptic meningitis.
Ulrich A; Weiler S; Weller M; Rordorf T; Tarnutzer AA
J Clin Neurosci; 2015 Jun; 22(6):1061-3. PubMed ID: 25769257
[TBL] [Abstract][Full Text] [Related]
17. Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review.
Nannini S; Koshenkova L; Baloglu S; Chaussemy D; Noël G; Schott R
J Neurooncol; 2022 May; 157(3):533-550. PubMed ID: 35416575
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous intracranial hypotension syndrome may mimic aseptic meningitis.
Balkan II; Albayram S; Ozaras R; Yilmaz MH; Ozbayrak M; Mete B; Yemisen M; Tabak F
Scand J Infect Dis; 2012 Jul; 44(7):481-8. PubMed ID: 22404365
[TBL] [Abstract][Full Text] [Related]
19. Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
Zhang M; Rodrigues AJ; Pollom EL; Gibbs IC; Soltys SG; Hancock SL; Neal JW; Padda SK; Ramchandran KJ; Wakelee HA; Chang SD; Lim M; Hayden Gephart M; Li G
J Neurooncol; 2021 Mar; 152(1):125-134. PubMed ID: 33415659
[TBL] [Abstract][Full Text] [Related]
20. Aseptic meningitis in relapsing polychondritis: a case report and literature review.
Shen K; Yin G; Yang C; Xie Q
Clin Rheumatol; 2018 Jan; 37(1):251-255. PubMed ID: 28361234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
